2-Deoxy-2-fluoro-D-glucopyranose

≥95%

Reagent Code: #103694
fingerprint
CAS Number 29702-43-0

science Other reagents with same CAS 29702-43-0

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 182.15 g/mol
Formula C₆H₁₁FO₅
badge Registry Numbers
MDL Number MFCD00077527
inventory_2 Storage & Handling
Storage 2-8°C

description Product Description

2-Deoxy-2-fluoro-D-glucopyranose is the non-radioactive analog of 2-deoxy-2-[18F]fluoro-D-glucose (FDG), a key radiotracer used in positron emission tomography (PET) scans. This compound serves as a reference standard, analytical reagent, or precursor in the synthesis and quality control of radiolabeled FDG for medical imaging applications.

FDG is primarily employed to detect and monitor cancer by visualizing metabolic activity (glucose uptake) in tissues, helping identify malignant cells. It also assesses the effectiveness of cancer treatments by tracking changes in tumor metabolism. In neurological studies, FDG aids in diagnosing and monitoring brain disorders such as Alzheimer's disease and Parkinson's disease by mapping glucose metabolism in the brain.

format_list_bulleted Product Specification

Test Parameter Specification
Appearance White To Off White/Yellow Solid
Purity (%) 94.5-100
Solubility 49.00-51.00 mg/ml, Water
Specific Rotation [α]20/D (C=1, Dil Ammonia Water) +60.0 - +65.0
Specific Rotation [A]20/D (C=1, Dil Ammonia Water) +60.0-+65.0 deg

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 10mg
10-20 days ฿3,591.00
inventory 25mg
10-20 days ฿8,550.00
inventory 100mg
10-20 days ฿31,500.00
$product.analytical_desc - NULL

Cart

No products

Subtotal: 0.00
Total 0.00 THB
2-Deoxy-2-fluoro-D-glucopyranose
No image available

2-Deoxy-2-fluoro-D-glucopyranose is the non-radioactive analog of 2-deoxy-2-[18F]fluoro-D-glucose (FDG), a key radiotracer used in positron emission tomography (PET) scans. This compound serves as a reference standard, analytical reagent, or precursor in the synthesis and quality control of radiolabeled FDG for medical imaging applications.

FDG is primarily employed to detect and monitor cancer by visualizing metabolic activity (glucose uptake) in tissues, helping identify malignant cell

2-Deoxy-2-fluoro-D-glucopyranose is the non-radioactive analog of 2-deoxy-2-[18F]fluoro-D-glucose (FDG), a key radiotracer used in positron emission tomography (PET) scans. This compound serves as a reference standard, analytical reagent, or precursor in the synthesis and quality control of radiolabeled FDG for medical imaging applications.

FDG is primarily employed to detect and monitor cancer by visualizing metabolic activity (glucose uptake) in tissues, helping identify malignant cells. It also assesses the effectiveness of cancer treatments by tracking changes in tumor metabolism. In neurological studies, FDG aids in diagnosing and monitoring brain disorders such as Alzheimer's disease and Parkinson's disease by mapping glucose metabolism in the brain.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...